Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 20;26(1):213.
doi: 10.1186/s13063-025-08896-6.

Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction: a study protocol for the Stop OsteoARthritis (SOAR) randomized controlled trial

Affiliations

Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction: a study protocol for the Stop OsteoARthritis (SOAR) randomized controlled trial

Jackie L Whittaker et al. Trials. .

Abstract

Background: People who tear their anterior cruciate ligament and have reconstruction surgery (ACLR) are at elevated risk of inactivity, obesity, and early-onset knee osteoarthritis. Consensus recommendations to prevent post-traumatic knee osteoarthritis include person-centered education and exercise-based treatments. The effectiveness of these recommendations is unknown. This study will assess if a digital education and exercise therapy intervention is superior to minimal intervention for improving knee-related symptoms, function, and quality of life in young people after ACLR.

Methods: The Stop OsteoARthritis (SOAR) study is a parallel, two-arm, assessor-blinded, superiority, hybrid effectiveness-implementation type 1 randomized controlled trial. After baseline testing, 166 participants aged 16-35 years, 9-36 months past, a first-time ACLR with ongoing symptoms will be randomly allocated to one of two treatment groups (1:1 ratio, stratified by sex). Ongoing symptoms will be defined as not meeting a Patient Acceptable Symptom State (PASS) on the averaged Knee injury and Osteoarthritis Outcome Score pain, symptoms function in sport and recreation, and quality-of-life subscales (KOOS4 < 79). Participants randomized to the experimental intervention will receive a digital (remote videoconferencing) 6-month program of group-based learning, individualized weekly home-based exercise therapy and physical activity program with tracking, and 1:1 physiotherapist-guided counseling. Participants randomized to the minimal intervention control group will receive an educational recording, best-practice guide for ACLR rehabilitation, one videoconferencing session, and tracking. The primary effectiveness outcome is the between-group difference in KOOS4 change from baseline to 6-months, with secondary endpoints at 12- and 24months. Secondary effectiveness outcomes include differences in the change of individual KOOS subscale scores, proportions of participants achieving KOOS subscale PASS scores, perceived self-management, and MRI features of knee OA. We will also assess secondary implementation (perceived barriers and facilitators of SOAR delivery), secondary efficiency (incremental cost-utility ratio), and exploratory outcomes. Missing data will be imputed and blinded intention-to-treat analyses performed.

Discussion: By assessing the effect, implementation, and efficiency of a digital education and exercise-based intervention designed to improve the knee health of young people at increased risk of knee osteoarthritis, this study will provide a basis for future scale-up to help curb the mounting burden of osteoarthritis.

Trial registration: ClinicalTrials.gov NCT06195423. Registered on December 22, 2023.

Keywords: Action planning; Education; Exercise therapy; Goal-setting; Physical therapy; Post-traumatic osteoarthritis; Prevention; Self-management; Telerehabilitation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate {24}: Ethical approval has been obtained from the University of British Columbia Clinical Research Ethics Board (CREB) on March 5, 2024 (REB #H23-03544) and all participants will provide informed consent. UBC CREB Contact Pia Ganz, CREB Manager (oversees the functioning of the CREB staff and Board, monitors ethical review process standards, and advises on compliance with ethics policies) pia.ganz@ubc.ca, Room 210, Research Pavilion, 828 West 10 th Avenue, Vancouver, BC, Canada V5Z 1M9. Consent for publication {32}: There is no pilot or baseline data or images of videos relating to an individual person in this study protocol. Competing interests {28}: JLW is supported by a Michael Smith Health Research British Columbia Scholar Award (SCH-2020–0403) and is a Senior Editor with the Journal of Orthopaedic and Sport Physical Therapy, associate editor with the British Journal of Sports Medicine, Arthritis Society (Canada) Integrated Scientific and Medical Advisory Committee member, and Data Safety and Monitoring Committee member for the PIKASO trial. JML is an associate editor of the Journal of Orthopaedic and Sports Physical Therapy. XHY is supported by the Faculty of Medicine Graduate Award (UBC). MM has received an honorarium from the Institute of Musculoskeletal Health and Arthritis, Canadian Institutes of Health Research. JCD is a Canada Research Chair (Tier 2) in Applied Health Economics and Michale Smith Health Research BC Scholar. The remaining authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Participant flow chart

References

    1. Yu D, Jordan KP, Bedson J, Englund M, Blyth F, Turkiewicz A, et al. Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992–2013. Rheumatology. 2017;56(11):1902–17. - PMC - PubMed
    1. Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG, et al. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508–22. - PMC - PubMed
    1. Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22. - PMC - PubMed
    1. Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2021;396(10267):2006–17. - PMC - PubMed
    1. Ackerman IN, Bohensky MA, Zomer E, Tacey M, Gorelik A, Brand CA, de Steiger R. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019;20(1):90. - PMC - PubMed

Publication types

MeSH terms

Associated data